News - BioSpace
WEBSeptember 12, 2024. ·. 4 min read. ·. Angela Gabriel. Load More. BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe. The latest biotech and pharmaceutical news ...
BioSpace: Biotech, Pharmaceutical and Clinical Research News
WEB2024 Q2 Job Market Report: More People Competing for Fewer Job Openings. For the second quarter of 2024, there were 25% fewer jobs posted live on BioSpace compared to the same quarter of 2023. The year-over-year job response rate rose from 14.6% to 15.3%. July 11, 2024. ·.
HEK 293 Cells: Background, Advantages and Applications
WEBJun 18, 2021 · Human Embryonic Kidney 293 (HEK 293) cells are one of the most frequently used cell lines for biotechnology and research studies. These cells are popular because they are fast-growing and robust. Additionally, due to the efficiency of HEK 293 cells, they generate exogenous proteins used in biomedical and pharmaceutical research.
9 Important Skills to Score a Job in the Pharmaceutical Industry
WEBNov 17, 2021 · When working a sales job in pharma, you need to be an excellent listener as well and engage with consumers in a convincing manner. You must also be emotionally intelligent to understand and recognize your coworkers’ and clients’ feelings. 4. Strategic Thinking and Creative Problem Solving.
Clinical research - BioSpace
WEBAug 12, 2024 · Pelage Pharmaceuticals Advances Clinical Program with First Patients Dosed in Phase 2 Study for Hair Loss and GV-Led $14M Series A-1. August 13, 2024. 4 min read. Sionna Therapeutics Announces Initiation of Two Phase 1 Clinical Trials of SION-719 and SION-451, in Development for Cystic Fibrosis.
AstraZeneca’s Imfinzi Scores Lung Cancer Wins With FDA’s
WEBAug 16, 2024 · AstraZeneca touted two lung cancer victories on Thursday with its blockbuster PD-1 inhibitor Imfinzi (durvalumab) securing the FDA’s nod for a perioperative label expansion in non-small cell lung cancer, as well as the regulator’s Priority Review and Breakthrough Therapy designations for small cell lung cancer.. The perioperative approval came as a bit of a surprise.
Novo’s Semaglutide Potentially Linked to Higher Risk of Suicidal ...
WEBAug 21, 2024 · Novo Nordisk ’s blockbuster GLP-1 treatment semaglutide—sold as Ozempic for type 2 diabetes and Wegovy for obesity—appears to be associated with a higher risk of suicidal ideation versus other drugs, according to a new study that drew from the World Health Organization’s safety database.. The results, published Tuesday in JAMA Network Open, are based on the WHO’s repository which ...
AstraZeneca’s Imfinzi-Lynparza Combo Wins Landmark EU Nod for ...
WEBAug 14, 2024 · The European Commission on Wednesday signed off on AstraZeneca ’s combination regimen of Imfinzi (durvalumab) and Lynparza (olaparib) for the treatment of certain endometrial cancer patients with advanced or recurrent disease.. The regulatory victory marks the “first-ever approval for a combination of an immunotherapy and PARP inhibitor in endometrial cancer,” Dave Fredrickson, executive ...
The Top 12 Biopharma Companies Hiring Now - BioSpace
WEBSep 5, 2018 · CSL Behring. 10. Gilead Sciences. 11. Resilience. 12. Bristol Myers Squibb Company. As you consider applying at these companies, remember to check out our job search toolkit, which features multiple resources to help you make your next career move. Angela Gabriel is content manager, life sciences careers, at BioSpace.
Novartis, Ono Latest to Announce Billion-Dollar M&A Deals
WEBMar 5, 2024 · Pictured: A collage of biopharma M&A/ Nicole Bean for BioSpace. After a slow 2022 and early part of 2023, the pace of mergers and acquisitions in the pharmaceutical and biotech sectors has accelerated since the middle of last year, highlighted by Pfizer’s $43 billion takeover of Seagen.Since the calendar turned to 2024, we have seen some blockbusters, including Novo Nordisk’s $16.5 billion ...
Skip to content